Feb 11 2010
SafeBridge® Consultants, Inc. (“SafeBridge”) headquartered in 
      Mountain View, California announced today that its industrial hygiene 
      analytical laboratory has recently validated an industrial hygiene air 
      sampling and analytical method with improved analytical sensitivity for 
      measurement of naproxen sodium on filters. SafeBridge now has a 
      validated method that will detect as low as 20 picograms per filter in 
      an air sample collected on appropriate media. This limit of detection is 
      four (4) to five (5) times lower than methods available from other 
      commercial laboratories.
    
    
      President and CEO John Farris commented, “Naproxen sodium can now be 
      measured at lower concentrations in air which creates an effective tool 
      for organizations involved in handling hazardous materials in powder and 
      liquid forms. This is important to pharmaceutical and chemical companies 
      as well as containment and engineering control vendors. Industrial 
      hygiene studies using sensitive methods can predict potential worker 
      exposures and identify sources of emissions for the purpose of 
      preventing occupational disease. Our chemists have done excellent and 
      scientifically supportable work to meet our customer needs”.
    
    
      SafeBridge’s industrial hygiene laboratory is accredited by the American 
      Industrial Hygiene Association (AIHA) for the analysis of active 
      pharmaceutical ingredients. The SafeBridge advantage is the application 
      of the most sensitive techniques in the industry to detect potent drugs 
      at very low concentrations in the workplace. The laboratory routinely 
      develops methods and analyzes samples that contain biologically active 
      pharmaceuticals such as steroid hormones, enzymes, peptide hormones, 
      antibody drug conjugates (ADCs) and “cytotoxic” compounds. The 
      SafeBridge laboratory is especially knowledgeable in the development of 
      immunoassays and application of ELISA technology to detect low 
      concentrations of highly potent drugs on filters.
    
    Source SAFEBRIDGE CONSULTANTS, INC.